1-3 of 3
Thomas Gajewski, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

WT1 Peptide Vaccine Is Able to Induce WT1-Specifc Immune Response with TCR Clonal Enrichment to Control Minimal Residual Disease in Patients with Myeloid Leukemia

Hongtao Liu, MD PhD, Yuanyuan Zha, PhD, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, PhD, Yusuke Nakamura, MD, Richard A. Larson, MD, Andres M Salazar, Olatoyosi Odenike, MD, Thomas Gajewski, MD PhD, Wendy Stock, MD
Journal: Blood
Blood (2016) 128 (22): 3984.
https://doi.org/10.1182/blood.V128.22.3984.3984
Published: 2016
Journal Articles

Innate Immune Sensing in Anti-Tumor Immunity and Cancer Immunotherapy

Thomas Gajewski, MD PhD
Journal: Blood
Blood (2016) 128 (22): SCI-27.
https://doi.org/10.1182/blood.V128.22.SCI-27.SCI-27
Published: 2016
Journal Articles

Prospective Study of Immunomodulation with GM-CSF, IL-2, and Rituximab Following Autologous Stem Cell Transplant (SCT) in Patients with Relapsed Lymphomas.

Sonali M. Smith, MD, David L. Grinblatt, MD, Thomas Gajewski, MD, PhD, Helena Harlin, PhD, Karen Welborne, BS, Kathy Conner, RN, Richard A. Larson, MD, Elizabeth Rich, MD, Olatoyosi Odenike, MD, Todd Zimmerman, MD, Koen van Besien, MD
Journal: Blood
Blood (2004) 104 (11): 918.
https://doi.org/10.1182/blood.V104.11.918.918
Published: 2004